Identification of dysregulated miRNAs and their regulatory signature in glioma patients using the partial least squares method

Shou,Jiajun; Gu,Shixin; Gu,Wentao

doi:10.3892/etm.2014.2041

Identification of dysregulated miRNAs and their regulatory signature in glioma patients using the partial least squares method

Authors:
- Jiajun Shou
- Shixin Gu
- Wentao Gu
View Affiliations

Affiliations: Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China
Published online on: October 31, 2014 https://doi.org/10.3892/etm.2014.2041
Pages: 167-171

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Using microarray data, the present study identified differentially expressed microRNAs (miRNAs) and evaluated their regulatory characteristics in high‑grade glioma patients, with the aim to further the understanding into the underlying etiology of the condition. Previously, studies have generally implemented regression or variance analysis, which ignores various background biological factors. However, in the present study, analysis was performed with microarray data collected from the Gene Expression Omnibus database using a partial least squares‑based method, which is more sensitive in handling microarray data. Among the six identified differentially expressed miRNAs, hsa‑miR‑21 and hsa‑miR‑612 have been previously reported to be associated with glioma. In addition, the remaining miRNAs, hsa‑miR‑4680, hsa‑miR‑1908, hsa‑miR‑4656 and hsa‑miR‑4467, may also contribute to glioma progression since they are all associated with the tumorigenesis of other types of cancer. Moreover, the expression levels of hsa‑miR‑1908, hsa‑miR‑4656 and hsa‑miR‑4680 have been identified to significantly correlate with the survival rate. Enrichment analysis of the dysregulated target genes revealed that the selected miRNAs primarily affect biological processes in the nervous system and the protein phosphorylation process. Therefore, the results may offer a new understanding into the pathogenesis of high‑grade glioma.

View Figures

View References

1	Goodenberger ML and Jenkins RB: Genetics of adult glioma. Cancer Genetics. 205:613–621. 2012. View Article : Google Scholar : PubMed/NCBI
2	Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
3	Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
4	Waldman SA and Terzic A: Translating microRNA discovery into clinical biomarkers in cancer. JAMA. 297:1923–1925. 2007. View Article : Google Scholar : PubMed/NCBI
5	Garzon R, Marcucci G and Croce CM: Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov. 9:775–789. 2010. View Article : Google Scholar : PubMed/NCBI
6	Li M, Li J, Liu L, Li W, Yang Y and Yuan J: MicroRNA in Human Glioma. Cancers (Basel). 5:1306–1331. 2013. View Article : Google Scholar
7	Visani M, de Biase D, Marucci G, et al: Definition of miRNAs expression profile in glioblastoma samples: the relevance of non-neoplastic brain reference. PloS One. 8:e553142013. View Article : Google Scholar : PubMed/NCBI
8	Yang C, Wang C, Chen X, et al: Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas. Int J Cancer. 132:116–127. 2013. View Article : Google Scholar
9	Chakraborty S and Datta S and Datta S: Surrogate variable analysis using partial least squares (SVA-PLS) in gene expression studies. Bioinformatics. 28:799–806. 2012. View Article : Google Scholar : PubMed/NCBI
10	Ji GL, Yang ZJ and You WJ: PLS-based gene selection and identification of tumor-specific genes. IEEE Trans Syst Man Cybern C Appl Rev. 41:830–841. 2011. View Article : Google Scholar
11	Gao QG, Li ZM and Wu KQ: Partial least squares based analysis of pathways in recurrent breast cancer. Eur Rev Med Pharmacol Sci. 17:2159–2165. 2013.PubMed/NCBI
12	Irizarry RA, Hobbs B, Collin F, et al: Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 4:249–264. 2003. View Article : Google Scholar : PubMed/NCBI
13	Martins JPA, Teófilo RF and Ferreira MMC: Computational performance and cross-validation error precision of five PLS algorithms using designed and real data sets. J Chemom. 24:320–332. 2010.
14	Gosselin R, Rodrigue D and Duchesne C: A bootstrap-VIP approach for selecting wavelength intervals in spectral imaging applications. Chemometr Intell Lab Syst. 100:12–21. 2010. View Article : Google Scholar
15	Smyth GK, Michaud J and Scott HS: Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics. 21:2067–2075. 2005. View Article : Google Scholar : PubMed/NCBI
16	Maragkakis M, Alexiou P, Papadopoulos GL, et al: Accurate microRNA target prediction correlates with protein repression levels. BMC Bioinformatics. 10:2952009. View Article : Google Scholar : PubMed/NCBI
17	John B, Enright AJ, Aravin A, Tuschl T, Sander C and Marks DS: Human MicroRNA targets. PLoS Biol. 2:e3632004. View Article : Google Scholar : PubMed/NCBI
18	Jeggari A, Marks DS and Larsson E: miRcode: a map of putative microRNA target sites in the long non-coding transcriptome. Bioinformatics. 28:2062–2063. 2012. View Article : Google Scholar : PubMed/NCBI
19	Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP and Burge CB: Prediction of mammalian microRNA targets. Cell. 115:787–798. 2003. View Article : Google Scholar : PubMed/NCBI
20	Shannon P, Markiel A, Ozier O, et al: Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
21	Hermansen SK, Dahlrot RH, Nielsen BS, Hansen S and Kristensen BW: MiR-21 expression in the tumor cell compartment holds unfavorable prognostic value in gliomas. J Neurooncol. 111:71–81. 2013. View Article : Google Scholar
22	Wu L, Li G, Feng D, et al: MicroRNA-21 expression is associated with overall survival in patients with glioma. Diagn Pathol. 8:2002013. View Article : Google Scholar : PubMed/NCBI
23	Li WB, Chen HY, Zhang W, et al: Relationship between magnetic resonance imaging features and miRNA gene expression in patients with glioblastoma multiforme. Chin Med J (Engl). 126:2881–2885. 2013.
24	Stambolic V, Suzuki A, de Pompa JL, et al: Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell. 95:29–39. 1998. View Article : Google Scholar : PubMed/NCBI
25	Long C, Jiang L, Wei F, et al: Integrated miRNA-mRNA analysis revealing the potential roles of miRNAs in chordomas. PloS One. 8:e666762013. View Article : Google Scholar : PubMed/NCBI
26	Jin JC, Jin XL, Zhang X, Piao YS and Liu SP: Effect of OSW-1 on microRNA expression profiles of hepatoma cells and functions of novel microRNAs. Mol Med Rep. 7:1831–1837. 2013.PubMed/NCBI
27	Pencheva N, Tran H, Buss C, et al: Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis. Cell. 151:1068–1082. 2012. View Article : Google Scholar : PubMed/NCBI
28	Persson H, Kvist A, Rego N, et al: Identification of new microRNAs in paired normal and tumor breast tissue suggests a dual role for the ERBB2/Her2 gene. Cancer Res. 71:78–86. 2011. View Article : Google Scholar : PubMed/NCBI
29	Wei KC, Huang CY, Chen PY, et al: Evaluation of the prognostic value of CD44 in glioblastoma multiforme. Anticancer Res. 30:253–259. 2010.PubMed/NCBI
30	Lonjon M, Quentien MH, Risso JJ, et al: Alteration of striatal dopaminergic function induced by glioma development: a microdialysis and immunohistological study in the rat striatum. Neuroscience Lett. 354:131–134. 2004. View Article : Google Scholar
31	Brun M, Glubrecht DD, Baksh S and Godbout R: Calcineurin regulates nuclear factor I dephosphorylation and activity in malignant glioma cell lines. J Biol Chem. 288:24104–24115. 2013. View Article : Google Scholar : PubMed/NCBI